Abstract
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress are considered the key determinants of insulin resistance. Impaired mitochondrial function in obese animals was shown to induce the ER stress response, resulting in reduced adiponectin synthesis in adipocytes. The expression of inducible nitric oxide synthase (iNOS) is increased in adipose tissues in genetic and dietary models of obesity. In this study, we examined whether activation of iNOS is responsible for palmitate-induced mitochondrial dysfunction, ER stress, and decreased adiponectin synthesis in 3T3L1 adipocytes. As expected, palmitate increased the expression levels of iNOS and ER stress response markers, and decreased mitochondrial contents. Treatment with iNOS inhibitor increased adiponectin synthesis and reversed the palmitate-induced ER stress response. However, the iNOS inhibitor did not affect the palmitate-induced decrease in mitochondrial contents. Chemicals that inhibit mitochondrial function increased iNOS expression and the ER stress response, whereas measures that increase mitochondrial biogenesis (rosiglitazone and adenoviral overexpression of nuclear respiratory factor-1) reversed them. Inhibition of mitochondrial biogenesis prevented the rosiglitazone-induced decrease in iNOS expression and increase in adiponectin synthesis. These results suggest that palmitate-induced mitochondrial dysfunction is the primary event that leads to iNOS induction, ER stress, and decreased adiponectin synthesis in cultured adipocytes.
Similar content being viewed by others
Introduction
Adipose tissue is an important endocrine organ that secretes many bioactive substances (adipocytokines). One of these, adiponectin, has many favorable effects on metabolism, including improvement of insulin action and reduction of atherosclerotic processes (Kadowaki et al., 2006; Koh et al., 2007). Unlike other adipocytokines, the plasma level of adiponectin is reduced in obese individuals (Kern et al., 2003; Scherer, 2006). We previously reported that mitochondrial function is essential for adiponectin synthesis in adipocytes, and that mitochondrial dysfunction in adipose tissue explains decreased adiponectin synthesis in obesity (Koh et al., 2007). Of particular interest in this study was the observation that impaired mitochondrial function activates a series of mechanisms involving endoplasmic reticulum (ER) stress, c-Jun N-terminal kinases (JNK), and activating transcription factor 3 (ATF3) to decrease adiponectin synthesis.
Nitric oxide (NO) is produced from L-arginine by the enzymatic action of NADPH-dependent NO synthases (NOS) (Chung et al., 2012). Among the known isoforms of NOS, activation of endothelial NOS (eNOS) is necessary for mitochondrial biogenesis (Nisoli et al., 2003) and adiponectin synthesis (Koh et al., 2010). Inducible NOS (iNOS) is also expressed in adipose tissue (Elizalde et al., 2000), and iNOS expression is increased in adipose tissues in genetic and dietary models of obesity (Perreault and Marette, 2001). In addition, obese mice lacking iNOS are sensitized to the metabolic actions of rosiglitazone, a peroxisome proliferator-activated receptor-γ (PPARγ) agonist, that result in increased plasma adiponectin levels (Dallaire et al., 2008).
Plasma levels of free fatty acids (FFAs) are increased in obese individuals and those with type 2 diabetes (Boden, 1997). FFAs have been shown to cause mitochondrial dysfunction and ER stress (Guo et al., 2007; Rachek et al., 2007). In particular, saturated fatty acids, i.e., palmitate and stearate, induce inflammation and insulin resistance in adipose tissue (Kennedy et al., 2009), whereas polyunsaturated fatty acids reduce body weight and insulin resistance (Kalupahana et al., 2010; Sato et al., 2010). Palmitate also decreases adiponectin synthesis (Xi et al., 2007) and increases iNOS expression in adipocytes (McCall et al., 2010).
In this study, we investigated the role of iNOS activation in the palmitate-induced decrease in adiponectin synthesis. As excessive NO produced by iNOS was shown to increase mitochondrial damage (Holohan et al., 2008), we hypothesized that palmitate-induced activation of iNOS would be primarily responsible for mitochondrial dysfunction and ER stress, and the consequent decrease in adiponectin synthesis. As expected, palmitate-induced iNOS expression was responsible for ER stress and decreased adiponectin synthesis. However, iNOS did not affect mitochondrial contents, and conversely, palmitate-induced mitochondrial dysfunction was responsible for iNOS induction.
Results
Palmitate decreases adiponectin synthesis and increases iNOS expression in cultured adipocytes
As reported previously (Xi et al., 2007), palmitate significantly decreased adiponectin expression in 3T3L1 adipocytes and its secretion into culture media (Figure 1A). Additionally, in agreement with a previous study (McCall et al., 2010), palmitate increased iNOS expression in cultured adipocytes (Figure 1B), and this was associated with increased NO synthesis by adipocytes as measured by the nitrite concentration in the media (Figure 1C). Palmitate decreased mitochondrial DNA (mtDNA) contents (Figure 1D) and the expression of mitochondrial respiratory proteins cytochrome C oxidase and cytochrome C (Figure 1B). Palmitate also decreased ATP levels and increased reactive oxygen species (ROS) generation (Figures 1E and F).
Inhibition of iNOS reverses palmitate-induced ER stress response but does not affect mitochondrial contents
Excessive NO is known to inhibit electron flow in the mitochondrial electron transport chain (ETC) and to increase ROS production and mitochondrial damage (Cassina and Radi, 1996). We therefore reasoned that iNOS inhibition would recover palmitate-induced decreases in mtDNA contents and mitochondrial protein expression. As expected, S-methylisothiourea sulfate (SMT), an iNOS-specific inhibitor, inhibited NO synthesis (Figure 2A), and recovered the palmitate-induced decrease in adiponectin expression (Figure 2B) and secretion into media (Figure 2C). However, contrary to our expectation, treatment with SMT did not affect mitochondrial DNA content (Figure 2D) or the expression of mitochondrial proteins (Figure 2E).
As previously reported (McCall et al., 2010), palmitate significantly increased the levels of ER stress response markers (anti-CCAAT/enhancer-binding protein (CHOP) and X-box binding protein 1 (XBP1) splicing) and the phosphorylation of JNK, a downstream signaling molecule of the ER stress response shown to be involved in adiponectin synthesis (Koh et al., 2007) in cultured adipocytes (Figure 2F). Inhibition of iNOS by SMT nearly completely reversed palmitate-induced changes in the ER stress response and JNK. Taken together, these results suggest that palmitate-induced activation of iNOS is responsible for the ER stress response and decreased adiponectin synthesis in cultured adipocytes, but is not responsible for changes in mitochondrial contents.
Mitochondrial dysfunction decreases adiponectin synthesis by increasing iNOS expression
We previously showed that various chemicals that inhibit mitochondrial function [indinavir, chloramphenicol, tumor necrosis factor-α (TNF-α), carbonyl cyanide m-chlorophenyl hydrazone (CCCP), and oligomycin] reduce adiponectin synthesis, and increase the ER stress response (Koh et al., 2007). To determine whether this effect is mediated by iNOS, we examined the effects of these chemicals on iNOS expression. iNOS expression was significantly increased by these chemicals (Figure 3A). SMT significantly decreased XBP1 splicing induced by these chemicals (Figure 3B) and increased adiponectin synthesis (Figure 3C).
Increased mitochondrial biogenesis decreases iNOS expression in cultured adipocytes
We next questioned whether the palmitate-induced increase in iNOS expression is mediated by mitochondrial dysfunction. Increased mitochondrial biogenesis improves mitochondrial function (Spiegelman, 2007; Wang et al., 2010), and rosiglitazone increases adiponectin synthesis in adipocytes by increasing mitochondrial biogenesis (Koh et al., 2007). In this study, we examined the effects of mtTFA siRNA on rosiglitazone-induced changes in iNOS expression. As expected (Wilson-Fritch et al., 2004; Koh et al., 2007), rosiglitazone increased adiponectin secretion, and this was accompanied by a decrease in the expression of iNOS in cultured 3T3L1 adipocytes (Figures 4B and 4C). These effects of rosiglitazone were significantly lower in cells pre-treated with siRNA against mitochondrial transcription factor A (mtTFA), a mitochondrial matrix protein essential for the replication and transcription of mtDNA (Kelly and Scarpullar, 2004) (Figures 4A-4C). To further confirm the reducing effect of increased mitochondrial biogenesis on iNOS expression, we examined the effect of nuclear respiratory factor-1 (NRF-1) overexpression. NRF-1 is a transcription factor that regulates the expression of nuclear-encoded mitochondrial genes, including mtTFA. Adenovirus-mediated overexpression of NRF-1 (Ad-NRF-1) decreased iNOS expression in the presence of palmitate, and this was accompanied by an increase in adiponectin synthesis (Figures 4D and 4E). siRNA against mtTFA reversed the effects of Ad-NRF-1 on iNOS expression and adiponectin synthesis (Figures 4D and 4E). Together, these results suggest that mitochondrial dysfunction induces ER stress by increasing iNOS expression in adipocytes, and that improved mitochondrial function by mitochondrial biogenesis reduces iNOS expression and increases adiponectin synthesis.
Discussion
Accumulating evidence indicates that NO produced by NOS plays a crucial role in energy metabolism (Kapur et al., 2000). Among the known types of NOS, iNOS produces high concentrations of NO in response to various inflammatory signals (Nathan and Xie, 1994). iNOS is also expressed in tissues other than inflamed tissues, and its expression is increased in adipose tissue and muscle in animal models of dietary and genetic obesity (Zhou et al., 2000; Perreault et al., 2001). iNOS-/- mice are protected from high fat-induced insulin resistance (Perreault et al., 2001).
Mitochondrial function was shown to be essential for adiponectin synthesis in adipocytes (Koh et al., 2007). In the present study, we showed that palmitate-induced mitochondrial dysfunction induced iNOS expression, and that this was responsible for ER stress and reduced adiponectin synthesis in cultured 3T3L1 adipocytes. Our results are consistent with those of a previous study, which showed that excessive NO downregulates the gene expression and secretion of adiponectin (Nozaki et al., 2007). A recent study also showed that the effect of rosiglitazone on adiponectin levels was markedly increased in iNOS-/- mice (Dallaire et al., 2008).
Excessive NO in the cell has been shown to increase mitochondrial damage and to cause mitochondrial dysfunction by inhibiting mitochondrial ETC (Cassina and Radi, 1996). We therefore reasoned that iNOS inhibitor would recover palmitate-induced decreases in mtDNA and mitochondrial protein expression. As expected (Crunkhorn et al., 2007; Rachek et al., 2007), palmitate significantly decreased mtDNA content and mitochondrial protein levels. However, iNOS inhibition by SMT did not increase mtDNA content or the expression of mitochondrial respiratory proteins. In our study, chemicals that cause mitochondrial dysfunction induced iNOS expression in cultured adipocytes. Although this particular experiment has not been performed before, this is consistent with previous studies (Yang et al., 2002; Lee and Wei, 2005).
In this study, we found that rosiglitazone, a PPARγ agonist, decreased iNOS expression in cultured adipocytes. This finding is consistent with previous studies: various PPARγ agonists have been shown to inhibit iNOS expression in islet cells (Abaraviciene et al., 2008), myocardium (Liu et al., 2004), lung (Cuzzocrea et al., 2004), and 3T3L1 adipocytes, and in the epididymal fat of Otsuka Long-Evans Tokushima Fatty rats (Linscheid et al., 2003). PPARγ agonists increase mitochondrial biogenesis (Wilson-Fritch et al., 2004; Koh et al., 2007), and increased mitochondrial biogenesis is known to improve mitochondrial function (Wenz et al., 2008). Our data, which indicate that rosiglitazone and Ad-NRF-1 reversed the palmitate-induced increase in iNOS expression, and that treatment with siRNA against mtTFA reversed the rosiglitazone- and Ad-NRF-1-induced decreases in iNOS expression, suggest that palmitate-induced mitochondrial dysfunction is responsible for iNOS induction.
Palmitate was shown to induce iNOS production (Tsang et al., 2004), mitochondrial dysfunction (Yuzefovych et al., 2010) and ER stress (Green and Olson, 2011). The novelty of our study is that we showed the sequence of these events. We provided new evidence that mitochondrial dysfunction is the primary cause of iNOS induction, ER stress response and decreased adiponectin synthesis (Supplemental Figure S1). However, excessive NO in the cell is known to increase mitochondrial damage and to cause mitochondrial dysfunction by inhibiting mitochondrial electron-transfer complexes (Cassina and Radi, 1996). This effect of NO may help the cells withstand severe stress by reducing intracellular ROS generation (Poliandri et al., 2006). However, it may also result in a vicious cycle, in which mitochondrial dysfunction leads to iNOS induction, NO increases, and further mitochondrial dysfunction.
In summary, we have demonstrated that palmitate-induced mitochondrial dysfunction induces iNOS expression and the ER stress response, and reduces adiponectin synthesis in cultured adipocytes. Increases in mitochondrial biogenesis by Ad-NRF-1 or rosiglitazone decreased iNOS expression and ER stress, and this was reversed by siRNA against mtTFA. The iNOS inhibitor SMT increased adiponectin synthesis by reducing ER stress, but did not affect mitochondrial contents. Taken together, these results suggest that palmitate-induced mitochondrial dysfunction is the primary event that leads to iNOS induction, ER stress, and decreased adiponectin synthesis in cultured adipocytes. Excessive NO produced by iNOS links mitochondrial dysfunction to ER stress and decreased adiponectin synthesis.
Methods
Cell culture
3T3L1 fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum in an incubator with 5% CO2/95% O2 at 37℃. 3T3L1 pre-adipocytes were differentiated to mature adipocytes by a conventional method (Koh et al., 2007) and were maintained as subconfluent cultures.
Measurement of adiponectin concentration
Adiponectin concentrations in the culture media were measured by an enzyme-linked immunosorbent assay (ELISA) kit (Alpco Diagnostics, Salem, NH) according to the manufacturer's instructions.
Measurement of nitrite concentration
Nitrite concentrations in the culture media were measured by the Total Nitric Oxide Assay kit (Assay Designs, Ann Arbor, MI) according to the manufacturer's instructions.
Measurement of ROS levels
Intracellular ROS generation was measured by flow cytometry using DCFH2-DA (Molecular Probes, Eugene, OR). For measurement of intracellular ROS levels, cells were incubated for 15 min with 2.5 µmol/ml DCFH2-DA at 37℃ for 30 min. The increase in DCFH2-DA oxidation was measured by a flow cytometry (FACSCalibur, San Jose, CA). Fluorescence was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
Measurement of intracellular ATP levels
Intracellular ATP levels were measured using an ATP determination kit (BioVision, Mountain View, CA) according to manufacturer's instructions.
Western blot analysis
Differentiated 3T3L1 cells were lysed in a buffer containing 20 mM Tris-HCl (pH 7.4), 1 mM EDTA, 140 mM NaCl, 1% NP-40, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaF, and 10 µg/ml aprotinin. The protein (40-50 µg) was subjected to immunoblotting with specific antibodies. Antibodies against phospho-JNK and cytochrome C oxidase were from Cell Signaling Technology (Beverly, MA). Antibodies against CHOP and mtTFA antibody were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-iNOS, anti-cytochrome C antibody, and anti-β-actin were from BD Biosciences (San Jose, CA) and Sigma-Aldrich (St Louis, MO), respectively.
Analysis of spliced XBP1 mRNA
XBP1 is a critical regulator of ER function and the ER stress response (Hotamisligil, 2006). Upon activation of the unfolded protein response, XBP1 mRNA is spliced by IRE1 to remove a 26-nucleotide intron and generate a translational frame shift. The resulting spliced mRNA (active form) encodes a protein with a novel carboxy-terminus that acts as a potent transcriptional activator. The target segment of the XBP1 cDNA was amplified by polymerase chain reaction (PCR) amplication. After separating the restriction digests, the cDNA fragments were resolved on 2% agarose gel. XBP1 splicing was measured by PCR using the following primers: forward, 5'-AAACAGAGTAGCAGCGCA GACTGC-3', reverse, 5'-GGATCTCTAAAACTAGAGGCTT GGTG-3'. The PCR procedure included an initial incubation for 3 minutes at 92℃, followed by 40 cycles of 45 seconds at 92℃, 45 seconds at 52℃, and 45 seconds at 72℃, and a final incubation for 10 minutes at 72℃. The amplified fragment was then digested by the restriction endonuclease PstI for 2 hours at 37℃ to reveal a restriction site that is lost after IRE1-mediated cleavage and splicing of the mRNA. After separating the restriction digests, the cDNA fragments were resolved on a 2% agarose gel.
Small interfering RNA (siRNA)
We designed two different siRNAs targeting different sequences of mtTFA: 5'-GUACAUUUUGGGAAAGUAA-3' and 5'-GUCACUGACAAGUUUGCAAdTdT-3'. We also made control siRNAs, which have the same GC content as the target sequences and do not cause silencing of gene expression (Bioneer, Daejon, Korea). Aliquots of 1.5 × 105 cells were seeded into each well of 6-well plates and transfected with 100 pmol siRNA using lipofectamine (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions.
Quantification of mtDNA content
mtDNA contents were quantified by real-time PCR on an ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA) using a SYBR Green kit (Applied Biosystems) according to the manufacturer's protocol. Mouse nuclear 18S rRNA was used as the internal control. The ratio of the expression level of the target gene to that of the 18S rRNA was calculated by subtracting the Ct (threshold cycle) value of the target gene from the Ct value of 18S rRNA. Primers for detecting the cytochrome b gene (14,146-15,289) from the murine mitochondrial genome were designed on the basis of the GenBank nucleotide sequence. The primer sequences were: forward, 5'- CCA CTT CAT CTT ACC ATT TA -3'; reverse, 5'-ATC TGC ATC TGA GTT TAA TC-3' (GenBank AB042432.1, Mus musculus domesticus mitochondrion) (Koh et al., 2007).
Recombinant adenovirus
NRF-1 adenovirus was a kind gift from Prof. Y. K. Pak (Kyung Hee University, Seoul, Korea).
Statistical analysis
All values are given as mean ± SEM. Differences between two groups were assessed using unpaired two-tailed t-test. Data from more than two groups were assessed by analysis of variance (ANOVA) followed by a post-hoc least significant difference test. P < 0.05 was considered statistically significant.
Abbreviations
- ATF3:
-
activating transcription factor 3
- CCCP:
-
carbonyl cyanide m-chlorophenyl hydrazone
- CHOP:
-
CCAAT/enhancer-binding protein
- eNOS:
-
endothelial nitric oxide synthase
- ER:
-
endoplasmic reticulum
- ETC:
-
electron transport chain
- FFA:
-
free fatty acid
- JNK:
-
c-Jun N-terminal kinases
- iNOS:
-
inducible nitric oxide synthase
- mtDNA:
-
mitochondrial DNA
- mtTFA:
-
mitochondrial transcription factor A
- NO:
-
nitric oxide
- NRF-1:
-
nuclear respiratory factor-1
- PPARγ:
-
peroxisome proliferator-activated receptor-γ
- ROS:
-
reactive oxygen species
- SMT:
-
S-methylisothiourea sulfate
- TNF-α:
-
tumor necrosis factor-α
- XBP1:
-
X-box binding protein 1
References
Abaraviciene SM, Lundquist I, Salehi A . Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities . Cell Mol Life Sci 2008 ; 65 : 2256 - 2265
Boden G . Role of fatty acids in the pathogenesis of insulin resistance and NIDDM . Diabetes 1997 ; 46 : 3 - 10
Cassina A, Radi R . Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport . Arch Biochem Biophys 1996 ; 328 : 309 - 316
Chung BH, Kim S, Kim JD, Lee JJ, Baek YY, Jeoung D, Lee H, Choe J, Ha KS, Won MH, Kwon YG, Kim YM . Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase . Exp Mol Med 2012 ; 44 : 191 - 201
Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, Faucette R, Barry K, Bianco AC, Patti ME . Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation . J Biol Chem 2007 ; 282 : 15439 - 15450
Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NS, Di Paola R, Ialenti A, Genovese T, Chatteriee PK, Di Rosa M, Caputi AP, Thiemermann C . Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation . Eur J Pharmacol 2004 ; 483 : 79 - 93
Dallaire P, Bellmann K, Laplante M, Gelinas S, Centeno-Baez C, Penfornis P, Peyot ML, Latour MG, Lamontagne J, Trujillo ME, Scherer PE, Prentki M, Deshaies Y, Marette A . Obese mice lacking inducible nitric oxide synthase aresensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism . Diabetes 2008 ; 57 : 1999 - 2011
Elizalde M, Ryden M, van Harmelen V, Eneroth P, Gyllenhammar H, Holm C, Ramel S, Olund A, Arner P, Andersson K . Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans . J Lipid Res 2000 ; 41 : 1244 - 1251
Green CD, Olson LK . Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic beta-cells by stearoyl-CoA desaturase and Elovl6 . Am J Physiol Endocrinol Metab 2011 ; 300 : E640 - E649
Guo W, Wong S, Xie W, Lei T, Luo Z . Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes . Am J Physiol Endocrinol Metab 2007 ; 293 : E576 - E586
Holohan C, Szegezdi E, Ritter T, O'Brien T, Samali A . Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL . J Cell Mol Med 2008 ; 12 : 591 - 606
Hotamisligil GS . Inflammation and metabolic disorders . Nature 2006 ; 444 : 860 - 867
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K . Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome . J Clin Invest 2006 ; 116 : 1784 - 1792
Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N . Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation . J Nutr 2010 ; 140 : 1915 - 1922
Kapur S, Picard F, Perreault M, Deshaies Y, Marette A . Nitric oxide: a new player in the modulation of energy metabolism . Int J Obes Relat Metab Disord 2000 ; 24 : S36 - S40
Kelly DP, Scarpullar RC . Transcriptional regulatory circuits controlling mitochondrial biogenesis and function . Genes Dev 2004 ; 18 : 357 - 368
Kennedy A, Martinez K, Chuang CC, LaPoint K, Mclntosh M . Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications . J Nutr 2009 ; 139 : 1 - 4
Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G . Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression . Diabetes 2003 ; 52 : 1779 - 1785
Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, Kim SY, Kim MS, Kim SW, Park IS, Youn JH, Lee KU . Essential role of mitochondrial function in adiponectin synthesis in adipocytes . Diabetes 2007 ; 56 : 2973 - 2981
Koh EH, Kim M, Ranjan KC, Kim HS, Park HS, Oh KS, Park IS, Lee WJ, Kim MS, Park JY, Youn JH, Lee KU . eNOS plays a major role in adiponectin synthesis in adipocytes . Am J Physiol Endocrinol Metab 2010 ; 298 : E846 - E853
Lee HC, Wei YH . Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress . Int J Biochem Cell Biol 2005 ; 37 : 822 - 834
Linscheid P, Keller U, Blau N, Schaer DJ, Muller B . Diminished production of nitric oxide synthase cofactor tetrahydrobiopterin by rosiglitazone in adipocytes . Biochem Pharmacol 2003 ; 65 : 593 - 598
Liu HR, Tao L, Gao E, Lopez BL, Christopher TA, Willette RN, Ohlstein EH, Yue TL, Ma XL . Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion . Cardiovasc Res 2004 ; 62 : 135 - 144
McCall KD, Holliday D, Dickerson E, Wallace B, Schwartz AL, Schwartz C, Lewis CJ, Kohn LD, Schwartz FL . Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages . J Endocrinol 2010 ; 207 : 343 - 353
Nathan C, Xie QW . Nitric oxide synthases: roles, tolls, and controls . Cell 1994 ; 78 : 915 - 918
Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO . Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide . Science 2003 ; 299 : 896 - 899
Nozaki M, Fukuhara A, Segawa K, Okuno Y, Abe M, Hosogai N, Matsuda M, Komuro R, Shimomura I . Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes . Biochem Biophys Res Commun 2007 ; 364 : 33 - 39
Perreault M, Marette A . Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle . Nat Med 2001 ; 7 : 1138 - 1143
Poliandri AH, Machiavelli LI, Quinteros AF, Cabilla JP, Duvilanski BH . Nitric oxide protects the mitochondria of anterior pituitary cells and prevents cadmium-induced cell death by reducing oxidative stress . Free Radic Biol Med 2006 ; 40 : 679 - 688
Rachek LI, Musiyenko SI, LeDoux SP, Wilson GL . Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells . Endocrinology 2007 ; 148 : 293 - 299
Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, Mizuquchi K, Itoh M, Suganami T, Ogawa Y . Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis . Diabetes 2010 ; 59 : 2495 - 2504
Scherer PE . Adipose tissue: from lipid storage compartment to endocrine organ . Diabetes 2006 ; 55 : 1537 - 1545
Spiegelman BM . Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators . Novartis Found Symp 2007 ; 287 : 60 - 63
Tsang MY, Cowie SE, Rabkin SW . Palmitate increases nitric oxide synthase activity that is involved in palmitate-induced cell death in cardiomyocytes . Nitric Oxide 2004 ; 10 : 11 - 19
Wang P, Liu J, Li Y, Wu S, Luo J, Yang H, Subbiah R, Chatham J, Zhelyabovska O, Yang Q . Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart . Circ Res 2010 ; 106 : 911 - 919
Wenz T, Diaz F, Spiegelman BM, Moraes CT . Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype . Cell Metab 2008 ; 8 : 249 - 256
Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP, Corvera S . Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone . J Clin Invest 2004 ; 114 : 1281 - 1289
Xi L, Qian Z, Xu G, Zhou C, Sun S . Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes . Br J Pharmacol 2007 ; 151 : 610 - 617
Yang JY, Koo BS, Kang MK, Rho HW, Sohn HS, Jhee EC, Park JW . Retinoic acid inhibits inducible nitric oxide synthase expression in 3T3-L1 adipocytes . Exp Mol Med 2002 ; 34 : 353 - 360
Yuzefovych L, Wilson G, Rachek L . Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress . Am J Physiol Endocrinol Metab 2010 ; 299 : E1096 - E1105
Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH . Lipotoxic heart disease in obese rats: implications for human obesity . Proc Natl Acad Sci USA 2000 ; 97 : 1784 - 1789
Acknowledgements
This work was supported by a National Research Foundation grant funded by the Korean government, Ministry of Education, Science, and Technology (2009-0091988 to KUL).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Experimental & Molecular Medicine website
Supplementary information
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Jeon, M., Leem, J., Ko, M. et al. Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes. Exp Mol Med 44, 562–570 (2012). https://doi.org/10.3858/emm.2012.44.9.064
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3858/emm.2012.44.9.064
Keywords
This article is cited by
-
The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus
Archives of Pharmacal Research (2024)
-
Bupivacaine Induces ROS-Dependent Autophagic Damage in DRG Neurons via TUG1/mTOR in a High-Glucose Environment
Neurotoxicity Research (2022)
-
Palmitic acid is an intracellular signaling molecule involved in disease development
Cellular and Molecular Life Sciences (2019)
-
RETRACTED ARTICLE: Progranulin causes adipose insulin resistance via increased autophagy resulting from activated oxidative stress and endoplasmic reticulum stress
Lipids in Health and Disease (2017)
-
Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis
Apoptosis (2017)